Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients

NCT00517114 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Gastroesophageal Reflux
Laryngitis

Interventions

DRUG: Rabeprazole 20mg twice daily

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]